JP2018520647A5 - - Google Patents

Download PDF

Info

Publication number
JP2018520647A5
JP2018520647A5 JP2017558986A JP2017558986A JP2018520647A5 JP 2018520647 A5 JP2018520647 A5 JP 2018520647A5 JP 2017558986 A JP2017558986 A JP 2017558986A JP 2017558986 A JP2017558986 A JP 2017558986A JP 2018520647 A5 JP2018520647 A5 JP 2018520647A5
Authority
JP
Japan
Prior art keywords
composition
enzyme
biological sample
inactivating
amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017558986A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018520647A (ja
JP7044554B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2016/060263 external-priority patent/WO2016180747A1/en
Publication of JP2018520647A publication Critical patent/JP2018520647A/ja
Publication of JP2018520647A5 publication Critical patent/JP2018520647A5/ja
Application granted granted Critical
Publication of JP7044554B2 publication Critical patent/JP7044554B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017558986A 2015-05-10 2016-05-09 自動多重組織染色アッセイの間のアルカリホスファターゼ及びペルオキシダーゼ酵素の同時不活化のための組成物と方法 Active JP7044554B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562159297P 2015-05-10 2015-05-10
US62/159,297 2015-05-10
PCT/EP2016/060263 WO2016180747A1 (en) 2015-05-10 2016-05-09 Compositions and methods for simultaneous inactivation of alkaline phosphatase and peroxidase enzymes during automated multiplex tissue staining assays

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2020205107A Division JP2021058193A (ja) 2015-05-10 2020-12-10 自動多重組織染色アッセイの間のアルカリホスファターゼ及びペルオキシダーゼ酵素の同時不活化のための組成物と方法

Publications (3)

Publication Number Publication Date
JP2018520647A JP2018520647A (ja) 2018-08-02
JP2018520647A5 true JP2018520647A5 (enExample) 2019-05-30
JP7044554B2 JP7044554B2 (ja) 2022-03-30

Family

ID=55953158

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2017558986A Active JP7044554B2 (ja) 2015-05-10 2016-05-09 自動多重組織染色アッセイの間のアルカリホスファターゼ及びペルオキシダーゼ酵素の同時不活化のための組成物と方法
JP2020205107A Pending JP2021058193A (ja) 2015-05-10 2020-12-10 自動多重組織染色アッセイの間のアルカリホスファターゼ及びペルオキシダーゼ酵素の同時不活化のための組成物と方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2020205107A Pending JP2021058193A (ja) 2015-05-10 2020-12-10 自動多重組織染色アッセイの間のアルカリホスファターゼ及びペルオキシダーゼ酵素の同時不活化のための組成物と方法

Country Status (7)

Country Link
US (3) US11162877B2 (enExample)
EP (1) EP3295173B1 (enExample)
JP (2) JP7044554B2 (enExample)
CN (1) CN107980095A (enExample)
AU (1) AU2016261279B2 (enExample)
CA (1) CA2984701C (enExample)
WO (1) WO2016180747A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7455816B2 (ja) 2018-09-20 2024-03-26 ヴェンタナ メディカル システムズ, インク. クマリン系架橋試薬
US12195545B2 (en) 2018-12-25 2025-01-14 Hanx Biopharmaceutics, Inc Anti-OX40 monoclonal antibody and application thereof
EP4278181A1 (en) 2021-01-15 2023-11-22 Ventana Medical Systems, Inc. Storage stable caged haptens
WO2022156920A1 (en) 2021-01-25 2022-07-28 Ventana Medical Systems, Inc. Stained biological specimens including one or more biomarkers labeled with one or more detectable moieties
US12555497B2 (en) 2021-03-30 2026-02-17 Sato Corporation Label structure and label
WO2022223137A1 (en) 2021-04-18 2022-10-27 Ventana Medical Systems, Inc. Morphological marker staining
CN113552362B (zh) * 2021-07-23 2024-08-09 湖北百奥斯生物科技有限公司 一种新型信号放大的免疫荧光试剂盒
JP2026502116A (ja) 2022-12-23 2026-01-21 ヴェンタナ メディカル システムズ, インク. 抗原提示機構の構成要素を評価するための材料および方法ならびにそれらの使用
WO2025014787A1 (en) 2023-07-07 2025-01-16 Ventana Medical Systems, Inc. Brightfield triplex immunohistochemistry assay for evaluating the colocalization of the er, pr, and ki-67 biomarkers in cells

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3410400C2 (de) * 1984-03-21 1987-04-02 Titmus Eurocon Kontaktlinsen GmbH, 8750 Aschaffenburg Kontaktlinsenpflegesatz und Verfahren zur Pflege von Kontaktlinsen
US5595707A (en) 1990-03-02 1997-01-21 Ventana Medical Systems, Inc. Automated biological reaction apparatus
US5225325A (en) * 1990-03-02 1993-07-06 Ventana Medical Systems, Inc. Immunohistochemical staining method and reagents therefor
EP1025444B1 (en) * 1997-10-21 2005-03-02 Cancer Research Technology Limited Determination of cellular growth abnormality
US6582962B1 (en) 1998-02-27 2003-06-24 Ventana Medical Systems, Inc. Automated molecular pathology apparatus having independent slide heaters
EP2284543A3 (en) 1998-02-27 2015-05-27 Ventana Medical Systems, Inc. System and method of aspirating and dispensing reagent
US20030211630A1 (en) 1998-02-27 2003-11-13 Ventana Medical Systems, Inc. Automated molecular pathology apparatus having independent slide heaters
SE9804064D0 (sv) * 1998-11-25 1998-11-25 A & Science Invest Ab Medicinal product and method for treatment of conditions affecting neural stem cells or progenitor cells
US20050176072A1 (en) * 2002-06-21 2005-08-11 Martin Michelle D. MTA1 is a predictive and prognostic factor in human breast cancer
US20040248223A1 (en) * 2003-06-05 2004-12-09 Idexx Laboratories, Inc. Reduction of interfering peroxidase activity in peroxidase based detection methods
WO2005033333A2 (en) * 2003-10-07 2005-04-14 Dako Denmark A/S Methods and compositions for the diagnosis of cancer
JP5733734B2 (ja) * 2009-02-19 2015-06-10 国立大学法人 千葉大学 成長因子に誘発されるユークロマチン化(euchromatinization)に必要な、SRC−ファミリーチロシンキナーゼの核局在
WO2010117325A1 (en) 2009-04-08 2010-10-14 Olle Hernell New methods for treatment of inflammatory diseases
JP5627698B2 (ja) 2009-10-19 2014-11-19 ベンタナ メディカル システムズ, インコーポレイテッド 撮像システムおよび技法
BR112013030824A8 (pt) * 2011-06-01 2018-04-03 Actogenix Nv Bactéria gram-positiva, ácido necleico recombinante, composição farmacêutica e vetor
CA2928374C (en) 2011-09-09 2018-09-25 Ventana Medical Systems, Inc. Imaging systems, cassettes, and methods of using the same
CA2867144C (en) 2012-03-27 2019-07-02 Ventana Medical Systems, Inc. Signaling conjugates and methods of use

Similar Documents

Publication Publication Date Title
JP2018520647A5 (enExample)
Lu et al. Hyphal development in Candida albicans requires two temporally linked changes in promoter chromatin for initiation and maintenance
Wilson et al. Ubiquitylation and degradation of elongating RNA polymerase II: the last resort
Zhang et al. Differential regulation of the ten-eleven translocation (TET) family of dioxygenases by O-linked β-N-acetylglucosamine transferase (OGT)
Turner et al. Cloning and characterization of two NAD kinases from Arabidopsis. Identification of a calmodulin binding isoform
Bianchi et al. Dynamic transcription of ubiquitin genes under basal and stressful conditions and new insights into the multiple UBC transcript variants
Sultan et al. During the early stages of Staphylococcus aureus biofilm formation, induced neutrophil extracellular traps are degraded by autologous thermonuclease
Wang et al. Characterization of the dynamic germination of individual Clostridium difficile spores using Raman spectroscopy and differential interference contrast microscopy
Tsuda et al. Tyrosyl-DNA phosphodiesterase 2 (TDP2) repairs topoisomerase 1 DNA-protein crosslinks and 3′-blocking lesions in the absence of tyrosyl-DNA phosphodiesterase 1 (TDP1)
EP3596218A1 (en) Crispr effector system based diagnostics for virus detection
Zhang et al. Low long non-coding RNA HOTAIR expression is associated with down-regulation of Nrf2 in the spermatozoa of patients with asthenozoospermia or oligoasthenozoospermia
WO2007149699A3 (en) Desizing and scouring process
Pruneski et al. The Paf1 complex represses SER3 transcription in Saccharomyces cerevisiae by facilitating intergenic transcription-dependent nucleosome occupancy of the SER3 promoter
Cucinotta et al. The nucleosome acidic patch regulates the H2B K123 monoubiquitylation cascade and transcription elongation in Saccharomyces cerevisiae
Atack et al. Contribution of the stereospecific methionine sulphoxide reductases MsrA and MsrB to oxidative and nitrosative stress resistance in the food-borne pathogen Campylobacter jejuni
MX2021003845A (es) Composiciones para reducir el acido urico serico.
Hartmann et al. Murein Hydrolases in the Envelope of Escherichia coli: Properties in situ and Solubilization from the Envelope
Perez-Mendoza et al. N-Acetylglucosamine-dependent biofilm formation in Pectobacterium atrosepticum is cryptic and activated by elevated c-di-GMP levels
WO2016071497A1 (en) Analytical and diagnostic methods utilizing shigella flexneri apyrase
He et al. Stabilization of RNA encapsulated in silk
Liberio et al. The crude skin secretion of the pepper frog Leptodactylus labyrinthicus is rich in metallo and serine peptidases
Reuter et al. An NlpC/P60 protein catalyzes a key step in peptidoglycan recycling at the intersection of energy recovery, cell division and immune evasion in the intracellular pathogen Chlamydia trachomatis
Liang et al. Divergence of TORC1-mediated stress response leads to novel acquired stress resistance in a pathogenic yeast
JP2016509835A5 (enExample)
Srinivasa et al. A MAP kinase pathway is implicated in the pseudohyphal induction by hydrogen peroxide in Candica albicans